Bavencio, INN Avelumab

Beovu, INN Brolucizumab

Darzalex, INN Daratumumab

Eylea, INN Aflibercept

Imfinzi, INN Durvalumab

Kaftrio, INN Ivacaftor, tezacaftor, elexacaftor

Kalydeco, INN Ivacaftor

Keytruda, INN Pembrolizumab (melanoma)

Keytruda, INN Pembrolizumab (TNBC_PD_L1)

Keytruda, INN Pembrolizumab (earlyTNBC)

Keytruda, INN Pembrolizumab (RCC)

Keytruda, INN Pembrolizumab (Urothelial carcinoma)

Keytruda, INN Pembrolizumab (EC)

Lorviqua, INN Lorlatinib

Lynparza, INN Olaparib

Lynparza, INN Olaparib (Овариалният карцином)

Onpattro, INN Patisiran

Opdivo, INN Nivolumab (monoTx)

Opdivo, INN Nivolumab (plevra)

Opdivo, INN Nivolumab (+ipilimumab_esophag)

Opdivo, INN Nivolumab (HER2)

Opdivo, INN Nivolumab (mono_esopahg)

Polivy, INN Polatuzumab vedotin

Repatha, INN Evolocumab

Rinvoq, INN Upadacitinib (AD)

Rinvoq, INN Upadacitinib (UC)

Rozlytrek, INN Entrectinib

Skyrizi, INN Risankizumab (ПсА)

Tagrisso, INN Osimertinib

Tegsedi, INN Inotersen

Tecentriq, INN Atezolizumab

Verzenios, INN Abemaciclib

Xeljanz, INN Tofacitinib (AS)

Xeljanz, INN Tofacitinib (JIA)